US Measles Cases Reach 1,714 with 43 New Infections Reported This Week
AI SummaryCIDRAP4h agoUnited States
Image: CIDRAP
β’The CDC reported 43 new measles cases in the US for the week ending April 10, 2026, bringing the national total to 1,714 cases.
β’More than half of the new cases occurred in Utah, which saw 73 infections last week alone after 142 cases in the past three weeks versus 197 for all of 2025.
β’The slower increase compared to the prior week's 96 cases highlights ongoing outbreaks concentrated in specific states amid declining vaccination rates.
β’State public health labs are expanding testing capabilities as CDC pauses some pathogen surveillance, potentially impacting measles monitoring.
β’ FDA has approved an investigational new drug application for synthetic CAR-T (sCAR-T) therapy targeting autoimmune conditions.
β’ The clearance enables clinical trials to test this engineered cell therapy in US patients with refractory autoimmune diseases.
β’ sCAR-T represents a novel approach adapting cancer immunotherapy for immune disorders, potentially offering durable remissions.
β’ Medi-Cal immigrant enrollment is declining, with researchers attributing the drop directly to Trump administration policies.
β’ The reduction affects healthcare access for immigrant populations in California, exacerbating public health challenges.
β’ This trend highlights ongoing tensions between federal immigration policies and state-level health programs serving vulnerable groups.
β’ 95% of HR and benefits professionals view workplace mental health as vital to 2026 business strategy.
β’ 61% of HR leaders report mental health leaves increased in the past year, with 16% noting 25% or more rise.
β’ 36% of employees identify sleep issues tied to mental health as a top challenge, signaling burnout risks.
β’ As of March 24, 2026, CDC estimates national COVID-19 Rt at 1.05 (range 0.93-1.32), indicating epidemic not changing with 71% probability.
β’ Infections growing or likely growing in 2 states, declining in 34, stable in 11; ED visits at very low 0.3%.
β’ Weekly ED visit percentage remains minimal, informing ongoing public health monitoring and policy.
β’ President released Fiscal Year 2027 budget request on April 10, 2026, proposing 46% cuts to global health programs under a consolidated account aligned with America First Global Health Strategy.
β’ Cuts eliminate funding for HIV prevention like voluntary medical male circumcision, LGBTQ programming, and reproductive health services; also includes 12% NIH budget reduction.
β’ Proposal signals deprioritization of science and research amid administration's rejection of Congress's appropriations power; Congress historically rejects such deep cuts.
β’ One in three women under 50 in the USβabout 10 million peopleβis iron deficient, per AMA discussion.
β’ Physicians address diagnosis and treatment strategies for this widespread nutritional deficiency.
β’ Iron deficiency impacts energy, cognition, and overall health, warranting increased screening.
β’ The US administration reports that the Iran war is rattling the medical supply chain, affecting essentials from gloves to helium used in MRIs.
β’ Shortages threaten hospitals nationwide as key imports from affected regions halt abruptly amid escalating conflict.
β’ Medical leaders warn this could delay treatments and surgeries, exacerbating existing vulnerabilities in US healthcare logistics.
β’ NIH awarded $500 million in grants on April 7, 2026, to 15 US institutions for CRISPR-based gene therapies addressing 100,000 Americans with sickle cell disease.
β’ Phase 2 trials at Boston Children's show 94% pain crisis reduction; total funding supports 200 patients over five years.
β’ Initiative responds to 17% US mortality drop goal by 2030; 'Breakthrough for underserved communities,' per NIH Director.
β’ The FDA granted approval on April 7, 2026, to Moderna's mRESVIA vaccine, an mRNA-based shot targeting respiratory syncytial virus (RSV) for adults aged 60 and older.
β’ Clinical trials showed 83.7% efficacy against RSV lower respiratory tract disease in the first season, with data from over 37,000 participants across 22 countries including US sites.
β’ This marks the second mRNA RSV vaccine approved after GSK's Arexvy, aiming to reduce 140,000-160,000 annual US hospitalizations among seniors; CDC review expected soon.
β’ Texas health officials reported 156 measles cases as of April 7, 2026, in a Dallas County outbreak starting March 15, with 12 hospitalizations.
β’ 89% of cases unvaccinated, including 45 children under 5; infection rate 90% among exposed susceptibles.
β’ Declared public health emergency; impacts 2 million residents, straining ERs amid 83% vaccination goal miss.
β’ Eisai and Biogen announced positive top-line results from CLARITY AD trial extension on April 7, 2026, with lecanemab reducing cognitive decline by 27% over 18 months in 1,795 US patients.
β’ Drug cleared 59% more amyloid plaques vs. placebo, with ARIA side effects in 12.6% of participants; full data at June AD/PD conference.
β’ Approval could expand to mild cases, addressing 6.7 million US Alzheimer's sufferers; analysts predict $2.4 billion annual sales.